Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.drreddys.com | |
Market Cap | 102,679.14 Cr. | |
Enterprise Value(EV) | 100,716.34 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 313.41 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 19.64 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 41.54 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 1,611.04 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 3.82 | Calculated using Price: 6,155.15 |
Dividend Yield | 0.65 | Period Ending 2023-03 |
No. of Shares Subscribed | 16.68 Cr. | 166,818,266 Shares |
FaceValue | 5 | |
About Dr. Reddy's Laboratories Ltd. | ||
The company is a leading India-based pharmaceutical company headquartered and having its registered office in Hyderabad, Telangana, India. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the Company offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars and differentiated formulations. |
1 Day |
|
+2.05% |
1 Week |
|
+1.15% |
1 Month |
|
-4.30% |
3 Month |
|
+8.03% |
6 Month |
|
+12.32% |
1 Year |
|
+37.58% |
2 Year |
|
+41.53% |
5 Year |
|
+123.20% |
10 Year |
|
+138.56% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 26.63 | 18.95 | 10.2 | 7.4 | 14.75 | 13.76 | 11.82 | 11.93 | 21.36 | |
Return on Capital Employed (%) | 22.7 | 19.55 | 9.77 | 8.21 | 13.66 | 11.12 | 15.49 | 14.59 | 26.22 | |
Return on Assets (%) | 13.67 | 11.05 | 6.14 | 4.23 | 8.86 | 9.2 | 8.21 | 8.08 | 15.01 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 9,853 | 12,570 | 12,262 | 12,572 | 14,024 | 15,599 | 17,642 | 19,212 | 23,286 | 25,497 | |
Non Curr. Liab. | 1,678 | 877 | 456 | 2,538 | 2,113 | -808 | -197 | -508 | -278 | -167 | |
Curr. Liab. | 6,821 | 6,347 | 8,420 | 6,894 | 5,897 | 7,214 | 8,104 | 9,766 | 8,572 | 8,407 | |
Minority Int. | |||||||||||
Equity & Liab. | 18,353 | 19,794 | 21,138 | 22,004 | 22,034 | 22,005 | 25,548 | 28,470 | 31,580 | 33,736 | |
Non Curr. Assets | 6,476 | 8,000 | 11,454 | 11,505 | 10,924 | 9,406 | 10,998 | 10,682 | 11,264 | 11,997 | |
Curr. Assets | 11,877 | 11,794 | 9,684 | 10,498 | 11,110 | 12,599 | 14,535 | 17,788 | 20,316 | 21,740 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 18,353 | 19,794 | 21,138 | 22,004 | 22,034 | 22,005 | 25,548 | 28,470 | 31,580 | 33,736 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 15,023 | 15,568 | 14,196 | 14,281 | 15,448 | 17,517 | 19,048 | 21,545 | 24,670 | 27,213 | |
Other Income | 275 | 295 | 172 | 155 | 338 | 621 | 291 | 485 | 1,056 | 844 | |
Total Income | 15,298 | 15,863 | 14,368 | 14,436 | 15,786 | 18,138 | 19,339 | 22,030 | 25,725 | 28,056 | |
Total Expenditure | -11,530 | -11,983 | -11,724 | -11,930 | -12,270 | -15,047 | -15,178 | -17,778 | -18,321 | -19,585 | |
PBIDT | 3,769 | 3,880 | 2,644 | 2,506 | 3,516 | 3,091 | 4,161 | 4,252 | 7,405 | 8,471 | |
Interest | -109 | -83 | -63 | -79 | -89 | -98 | -97 | -96 | -143 | -147 | |
Depreciation | -760 | -939 | -1,027 | -1,077 | -1,135 | -1,163 | -1,229 | -1,165 | -1,250 | -1,418 | |
Taxation | -563 | -751 | -297 | -438 | -386 | 140 | -932 | -879 | -1,541 | -1,697 | |
Exceptional Items | |||||||||||
PAT | 2,336 | 2,108 | 1,257 | 912 | 1,950 | 2,026 | 1,952 | 2,183 | 4,507 | 5,209 | |
Minority Interest | |||||||||||
Share Associate | 23 | 35 | 34 | 19 | |||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 2,336 | 2,131 | 1,292 | 947 | 1,950 | 2,026 | 1,952 | 2,183 | 4,507 | 5,228 | |
Adjusted EPS | 137 | 125 | 78 | 57 | 117 | 122 | 117 | 131 | 271 | 314 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 1,970 | 2,524 | 3,263 | 2,144 | 1,803 | 2,870 | 2,984 | 3,570 | 2,811 | 5,888 | |
Cash Fr. Inv. | -1,694 | -2,265 | -2,039 | -1,840 | -1,488 | -773 | -492 | -2,266 | -2,639 | -4,137 | |
Cash Fr. Finan. | -24 | -433 | -1,700 | -369 | -444 | -2,133 | -2,516 | -30 | -242 | -2,686 | |
Net Change | 251 | -174 | -477 | -65 | -129 | -35 | -24 | 1,275 | -70 | -936 | |
Cash & Cash Eqvt | 862 | 583 | 492 | 378 | 254 | 223 | 196 | 1,482 | 1,485 | 578 |
Wed, 27 Mar 2024
Announcement under Regulation 30 (LODR)-Press Release / Media Release Disclosure under Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 |
Tue, 26 Mar 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Loss of Share Certificates |
Fri, 22 Mar 2024
Announcement Under Regulation 30 Of SEBI LODR Regulations Press Release |
Thu, 28 Mar 2024 |
Closing Above Previous High |
Close Within 52 Week High Zone |
High Increase in 1 Year |
High Increase in 5 Years |
Closing Near 50 SMA |